Adrastia Biotechnology was founded in 2013 to provide a highly accurate Breast Cancer diagnostic protocol that is easy to administer, non-invasive, will deliver rapid results, and provide women with a personal health history.
Adrastia Biotechnology obtains the urine sample and runs high throughput protein quantification and targeted mRNA/microRNA sequencing to identify a pattern of breast cancer positive or negative as compared to a standard or the woman's own previous pattern. Unlike 100% genomic data, Adrastia's test results are designed to be actionable by the woman's physician and her pattern will be stored in her health record for future reference.
Small (EDWOSB, SB#2001039) Technology Distribution company specializing in innovative products that enable healthcare workforce mobility and healthcare delivery efficiency.
ARIZ is a company dedicated to solving a big problem, cancer. We start at the beginning, the cause of cancer and design drugs that can resolve a specific individual cancer as well as all cancers. ARIZ Precision Medicine uses this methodology to design a specific way to stop the cause of cancer, then target and protect the delivery system and finally, concentrate the drug inside the cancer cell leaving normal cells undamaged.
Our scientists have dedicated a lifetime of research to develop a stable nanocarrier platforms for delivery of therapeutic and diagnostics agens with high potency and high accuracy. Our research is focused on the development of mucoadhesive protein-capsid-based drug delivery systems by drink. Astrid Pharma Corp offers solutions backed by ground-breaking scientific discoveries to make the "needle-free" drug administration dream, a reality.
Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We focus in three target markets to serve patients, physicians and partners:
Cellular Therapeutics
Medical/Diagnostic Device Development and Commercialization
Cell Manufacturing and Banking
Have you ever had a surgery?
Checking out of the hospital, you were likely you were given a list of products to help you recover.
Easy DME allows clinics to offer all of the products a patient needs to recover, delivered directly to their doorstep.
No more product scavenger hunts.
Easy DME helps clinics to increase revenue while adding a new convenient service to increase patient satisfaction.
We are addressing the opioid crisis in America and the vast unmet medical needs in pain management by developing a new class of pain drugs that was discovered by accident during our search for new and better general anesthetics. We are also working to reduce anesthetic costs and bring general anesthesia to the third of the world that lacks access through the development of new and better agents.
Davis-based Expanesthetics raises another $1.16 million in venture capital | Sacramento Business Journal, August 14, 2018
Davis-based Expanesthetics raises nearly $3 million | Sacramento Business Journal, September 25, 2017
Safer Lock is the first combination locking cap for prescription pill bottles. Protect your children and family members from accidental poisoning and prevent prescription drug addiction by securing your medication and supplements in a Safer Lock bottle.
Juno Biomedical, Inc was founded on a vision that it is possible for modern medicine to treat the root cause of disease. We are driven to do more than treat the symptoms; our mission is to give life back to those who have suffered a loss of function due to neurological damage after a stroke by developing a device that enhances the body’s natural reparative process to reverse the damage. CELLTech™ has been developed under an issued patent. The Juno Biomedical, Inc. team has been working closely with the FDA since 2018 as part of the Early Feasibility Study (EFS) Program. The purpose of the EFS program is to fast-track highly novel devices to the clinic. We are also in the process of working closely with federal funding bodies to support the CELLTech™ feasibility clinical trial.
